A New Way to Treat Inflammatory Bowel Disease - Cameron Turtle

Cameron Turtle is the CEO of Spyre Therapeutics. His team is developing a new class of therapies for ulcerative colitis and Crohn's disease that are more effective and convenient for patients. Expect to learn what life is like at a hyper-competitive consulting company, the skills needed to work at a start-up, and the steepest parts of the learning curve for a new CEO.

Cameron: https://www.linkedin.com/in/cameron-turtle-701b3533/

Spyre Therapeutics: https://spyre.com/

Sponsors: Sage Bionetworks - driving a new age of discovery through open science and radical collaboration https://sagebionetworks.org/

Get in touch: LinkedIn: https://www.linkedin.com/in/drew-duglan-phd/

Instagram: https://www.instagram.com/drdrewduglan

X: https://x.com/drdrewduglan

Email: [e-mail]

Watch on YouTube: https://www.youtube.com/@drdrewduglan